Shauna Mason

Title: The Innovative Contributions of Shauna Mason

Introduction

Shauna Mason is a prominent inventor based in Arlington, MA (US). She has made significant contributions to the field of biomedical research, particularly in the development of therapeutic antibodies. With a total of 4 patents to her name, her work has the potential to impact various medical conditions.

Latest Patents

Among her latest patents is the "Monoclonal antibody inhibitor of Factor XIIa." This patent discloses anti-Factor XIIa antibodies and methods for treating diseases associated with Factor XII, including conditions related to contact system activation, plasma prekallikrein signaling, hereditary angioedema, and ocular diseases. Another notable patent is for "Bispecific antibodies against plasma kallikrein and factor XII." This invention describes bispecific antibodies that bind to plasma kallikrein and Factor XII, along with methods for producing and using these antibodies to treat disorders associated with the contact system, such as hereditary angioedema or thrombosis.

Career Highlights

Shauna has worked with leading companies in the pharmaceutical industry, including Takeda Pharmaceutical Company Limited and Dyax Corporation. Her experience in these organizations has allowed her to develop her innovative ideas into practical applications.

Collaborations

Throughout her career, Shauna has collaborated with notable professionals in her field, including Jon A Kenniston and Andrew Nixon. These collaborations have further enriched her research and development efforts.

Conclusion

Shauna Mason's contributions to the field of biomedical research through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical treatments.